Latest Breaking News On - Agonist has added effect - Page 1 : comparemela.com

An editorial on phase 2 results from treating people with obesity or overweight but not diabetes with retatrutide, a triple hormone–receptor agonist, calls the weight loss achieved "unprecedented."

San diegoUnited statesNew havenYale universityLeem kaplanAniam jastreboffVictoza saxendaMary elizabeth pattiOzempic wegovyJulio rosenstockYale obesity research centerDrug administrationAmerican diabetes associationDallas diabetes research center at medical cityNutrition institute at massachusettsJoslin diabetes center